Repositori institucional URV
Español Català English
TITLE:
Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata - imarina:5129738

URV's Author/s:Capilla Luque, Javier / Guarro Artigas, Josep / Sanchis Talón, Marta
Author, as appears in the article.:Sanchis M; Capilla J; Castanheira M; Martin-Vicente A; Sutton DA; Fothergill AW; Wiederhold NP; Guarro J
Author's mail:marta.sanchis@urv.cat
javier.capilla@urv.cat
Author identifier:0000-0001-7251-6792
0000-0002-0765-6403
Journal publication year:2016
Publication Type:Journal Publications
ISSN:09248579
APA:Sanchis M; Capilla J; Castanheira M; Martin-Vicente A; Sutton DA; Fothergill AW; Wiederhold NP; Guarro J (2016). Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata. International Journal Of Antimicrobial Agents, 47(4), 286-288. DOI: 10.1016/j.ijantimicag.2015.12.020
Papper original source:International Journal Of Antimicrobial Agents. 47 (4): 286-288
Abstract:In this study, 27 clinical isolates of Candida glabrata with voriconazole (VRC) minimum inhibitory concentrations (MICs) ranging from ¿0.03 ¿g/mL to 8 ¿g/mL were tested to determine whether in vitro data are predictive of in vivo efficacy. The efficacy of VRC administered at 40 mg/kg was assayed in a neutropenic murine model of disseminated infection by C. glabrata. The reduction in fungal tissue burden in the kidneys was used as a marker of treatment efficacy. VRC reduced the fungal tissue burden in mice infected with strains that had MICs below the epidemiological cut-off value (ECV) of 0.25 ¿g/mL. Variable efficacy of VRC was obtained when the MIC equalled the ECV, and VRC was ineffective when the MIC exceeded the ECV. These results suggest that the use of in vitro data could be useful to predict the outcome for infections by this fungus.
Article's DOI:10.1016/j.ijantimicag.2015.12.020
Link to the original source:https://www.sciencedirect.com/science/article/abs/pii/S0924857916000431?via%3Dihub
Papper version:info:eu-repo/semantics/acceptedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Ciències Mèdiques Bàsiques
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Saúde coletiva
Química
Pharmacology (medical)
Pharmacology & pharmacy
Odontología
Nutrição
Microbiology (medical)
Microbiology
Medicine (miscellaneous)
Medicina veterinaria
Medicina iii
Medicina ii
Medicina i
Materiais
Interdisciplinar
Infectious diseases
General medicine
Farmacia
Engenharias iii
Engenharias ii
Enfermagem
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Ciências ambientais
Ciências agrárias i
Biotecnología
Biodiversidade
Keywords:Voriconazole
Resistance
Model
Mechanisms
Management
Liposomal amphotericin-b
Fungal infection
Fluconazole
Fks mutations
Epidemiological cut-off value
Efficacy
Combination
Caspofungin
Candida glabrata
Antifungals
Animal model
fungal infection
epidemiological cut-off value
candida glabrata
antifungals
animal model
Entity:Universitat Rovira i Virgili
Record's date:2024-09-07
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili